About
Technology
Issues
FAQ
Links
Official Page
Randomized trial of fenretinide (4‐HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: Long‐term results
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.